KRAS and acute myeloid leukemia: Gender, type of AML, mutational status of NPM1, DNMT3A, TET2, NRAS, K-RAS, IDH1, IDH2, TP53, FLT3-TKD genes encoding the chromatin/spliceosome complex, and adverse cytogenetics were not significantly associated with survival.